338 related articles for article (PubMed ID: 34091704)
21. Humoral response to COVID-19 infection in immunosuppressed patients with inflammatory bowel disease.
Scharrer S; Kutschera M; Weseslindtner L; Primas C; Vogelsang H
Eur J Gastroenterol Hepatol; 2021 Mar; 33(3):443-447. PubMed ID: 33522752
[TBL] [Abstract][Full Text] [Related]
22. Effect of Immunosuppressive Diseases and Rituximab Infusions on Allowing COVID-19 Infection to Relapse.
Prasad RM; Srivastava S; Wang E; Liu JZ; Gami R; Abdelgadir A; Sharma A; Rayamajhi S; Tikaria R
Perm J; 2021 Oct; 26(1):123-131. PubMed ID: 35609158
[TBL] [Abstract][Full Text] [Related]
23. Rituximab (MABTHERA) and severe polyangiitis. An option for patients informed of the uncertainties.
Prescrire Int; 2015 Jun; 24(161):145-8. PubMed ID: 26436161
[TBL] [Abstract][Full Text] [Related]
24. Validation of a SARS-CoV-2 RNA RT-PCR assay for high-throughput testing in blood of COVID-19 convalescent plasma donors and patients.
Strasser EF; Steininger PA; Korn K; Achenbach S; Tenbusch M; Cunningham S; Zimmermann R; Überla K; Hackstein H
Transfusion; 2021 Feb; 61(2):368-374. PubMed ID: 33125162
[TBL] [Abstract][Full Text] [Related]
25. Notes From the Field: The Combined Effects of Tocilizumab and Remdesivir in a Patient With Severe COVID-19 and Cytokine Release Syndrome.
Ali S; Khalid S; Afridi M; Akhtar S; Khader YS; Akhtar H
JMIR Public Health Surveill; 2021 May; 7(5):e27609. PubMed ID: 34009133
[TBL] [Abstract][Full Text] [Related]
26. Prolonged SARS-CoV-2 Infection in Patients Receiving Anti-CD20 Monoclonal Antibodies: A Diagnostic Challenged by Negative Nasopharyngeal RT-PCR and Successful Treatment with COVID-19 High-Titer Convalescent Plasma.
Da Silva L; Klopfenstein T; Gendrin V; Clouet J; Toko L; Richier Q; Leriche T; Nicolas R; Queijo A; Sreiri N; Lacombe K; Zayet S
Viruses; 2023 Nov; 15(11):. PubMed ID: 38005897
[TBL] [Abstract][Full Text] [Related]
27. Second COVID-19 infection in a patient with granulomatosis with polyangiitis on rituximab.
Friedman MA; Winthrop KL
Ann Rheum Dis; 2021 Aug; 80(8):1102-1104. PubMed ID: 33674264
[No Abstract] [Full Text] [Related]
28. Fulminant granulomatosis with polyangiitis presenting with diffuse alveolar haemorrhage following COVID-19.
Lind E; Jameson A; Kurban E
BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34155024
[TBL] [Abstract][Full Text] [Related]
29. A 63-Year-Old Woman with a History of Non-Hodgkin Lymphoma with Persistent SARS-CoV-2 Infection Who Was Seronegative and Treated with Convalescent Plasma.
Moore JL; Ganapathiraju PV; Kurtz CP; Wainscoat B
Am J Case Rep; 2020 Oct; 21():e927812. PubMed ID: 33009361
[TBL] [Abstract][Full Text] [Related]
30. A case of granulomatosis with polyangiitis and pyoderma gangrenosum successfully treated with infliximab and rituximab.
Donmez S; Pamuk ON; Gedik M; A K R; Bulut G
Int J Rheum Dis; 2014 May; 17(4):471-5. PubMed ID: 24460826
[TBL] [Abstract][Full Text] [Related]
31. A Retrospective Study on the Effects of Convalescent Plasma Therapy in 24 Patients Diagnosed with COVID-19 Pneumonia in February and March 2020 at 2 Centers in Wuhan, China.
Huang S; Shen C; Xia C; Huang X; Fu Y; Tian L
Med Sci Monit; 2020 Dec; 26():e928755. PubMed ID: 33264276
[TBL] [Abstract][Full Text] [Related]
32. A case of polyangiitis overlap syndrome of giant cell arteritis and granulomatosis with polyangiitis successfully treated with rituximab.
Shibata A; Kondo T; Kurasawa T; Chino K; Okada Y; Amano K
Mod Rheumatol Case Rep; 2021 Jul; 5(2):317-321. PubMed ID: 33250006
[TBL] [Abstract][Full Text] [Related]
33. Lesson of the month: Severe granulomatosis with polyangiitis (GPA): a diagnostic challenge during the COVID-19 pandemic.
Qurratulain Q; Ahmed A; Jones Q
Clin Med (Lond); 2021 Jan; 21(1):79-80. PubMed ID: 33479073
[TBL] [Abstract][Full Text] [Related]
34. Emerging RNA-Dependent RNA Polymerase Mutation in a Remdesivir-Treated B-cell Immunodeficient Patient With Protracted Coronavirus Disease 2019.
Martinot M; Jary A; Fafi-Kremer S; Leducq V; Delagreverie H; Garnier M; Pacanowski J; Mékinian A; Pirenne F; Tiberghien P; Calvez V; Humbrecht C; Marcelin AG; Lacombe K
Clin Infect Dis; 2021 Oct; 73(7):e1762-e1765. PubMed ID: 32986807
[TBL] [Abstract][Full Text] [Related]
35. Necrotising myopathy and concurrent thyroiditis in a patient with COVID-19 infection.
Reggio C; Paudel A; Specht CS; Donato AA
BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34083194
[TBL] [Abstract][Full Text] [Related]
36. The Successful Recovery of a Critically Ill COVID-19 Patient, Following the Combination of Therapeutic Plasma Exchange and Convalescent Plasma Transfusion: A Case Report.
Novacescu AN; Duma G; Sandesc D; Sorescu T; Licker M
Medicina (Kaunas); 2022 Aug; 58(8):. PubMed ID: 36013555
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic and therapeutic challenges for patients with ANCA-associated vasculitides at the time of COVID-19. Response to: 'Rituximab for granulomatosis with polyangiitis in the pandemic of COVID-19: lessons from a case with severe pneumonia' by Guilpain
Monti S; Montecucco C
Ann Rheum Dis; 2021 Jan; 80(1):e11. PubMed ID: 32354773
[No Abstract] [Full Text] [Related]
38. High-titre convalescent plasma therapy for an immunocompromised patient with systemic lupus erythematosus with protracted SARS-CoV-2 infection.
Moutinho-Pereira S; Calisto R; Sabio F; Guerreiro L
BMJ Case Rep; 2021 Aug; 14(8):. PubMed ID: 34433539
[TBL] [Abstract][Full Text] [Related]
39. Prolonged viral positivity induced recurrent coronavirus disease 2019 (COVID-19) pneumonia in patients receiving anti-CD20 monoclonal antibody treatment: Case reports.
Deveci B; Saba R
Medicine (Baltimore); 2021 Dec; 100(52):e28470. PubMed ID: 34967391
[TBL] [Abstract][Full Text] [Related]
40. Pneumocystis jiroveci pneumonia in rheumatic disease: a 20-year single-centre experience.
Mecoli CA; Saylor D; Gelber AC; Christopher-Stine L
Clin Exp Rheumatol; 2017; 35(4):671-673. PubMed ID: 28134084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
